The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Smagina I.V.

Otdelenie nevrologii kraevoĭ klinicheskoĭ bolnitsy, Barnaul;
kafedra nervnykh bolezneĭ s kursom nevrologii i refleksoterapii fakulteta povysheniia kvalifikatsii i PPS, Barnaul;
kafedra biokhimii i klinicheskoĭ laboratornoĭ diagnostiki Altaĭskogo gosudarstvennogo meditsinskogo universiteta, Barnaul;
Novosibirskiĭ gosudarstvennyĭ universitet, Novosibirsk

Fedianin A.S.

Kraevoe BUZ "Kraevaia klinicheskaia bol'nitsa", Barnaul

Elchaninova S.A.

Lobanov M.N.

Zolovkina A.G.

Authors:

Smagina I.V., Fedianin A.S., Elchaninova S.A., Lobanov M.N., Zolovkina A.G.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(11): 53‑55

Read: 538 times

Contact the author
Table of contents

To cite this article:

Smagina IV, Fedianin AS, Elchaninova SA, Lobanov MN, Zolovkina AG. . S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(11):53‑55. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Study of neurodegeneration in multiple scle­rosis using opti­cal cohe­rence tomo­graphy of the retina and magnetic reso­nance morphometry of the brain. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):66-72
Resu­lts of a 5-year project for the early diagnosis of multiple scle­rosis in first-line blood rela­tives (RADIRS program). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):28-33
Resu­lts of 4 years of therapy with divo­zilimab in patients with rela­psing multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):51-59
The role of mono­cytes in the immu­nopathogenesis of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):23-27
Effect of urolithin A on production of inte­rleukins 6 and 10 by immune cells from patients with MS and healthy donors. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):84-88
Mole­cular mechanisms of acute disseminated ence­phalomyelitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):7-11
Evaluation of the effect of highly effe­ctive multiple scle­rosis disease-modifying drugs on the progression of the disease using diffusion-weighted magnetic reso­nance imaging with tractography. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):73-78
Myoadaptive overload syndromes of lower extremities in multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):89-93
Quantitative analysis of cere­brospinal fluid flow in multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):45-50
Features of the clinical course of multiple scle­rosis as a factor in persistent disa­bility. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):39-44
Abstract:

Levels of adhesion molecules were measured in 24 patients with multiple sclerosis during the 3-years prospective study. The high level of adhesion molecules sPECAM in the cerebrospinal fluid was associated with the appearance of new foci according to the magnetic resonance imaging data as well as with quick disability.

Authors:

Smagina I.V.

Otdelenie nevrologii kraevoĭ klinicheskoĭ bolnitsy, Barnaul;
kafedra nervnykh bolezneĭ s kursom nevrologii i refleksoterapii fakulteta povysheniia kvalifikatsii i PPS, Barnaul;
kafedra biokhimii i klinicheskoĭ laboratornoĭ diagnostiki Altaĭskogo gosudarstvennogo meditsinskogo universiteta, Barnaul;
Novosibirskiĭ gosudarstvennyĭ universitet, Novosibirsk

Fedianin A.S.

Kraevoe BUZ "Kraevaia klinicheskaia bol'nitsa", Barnaul

Elchaninova S.A.

Lobanov M.N.

Zolovkina A.G.

Close metadata

References:

  1. Gusev E.I., Zavalishin I.A., Boiko A.N. Rasseyannyi skleroz i drugie demieliniziruyushchie zabolevaniya. M: Miklosh 2004; 540.
  2. El'chaninova S.A., Smagina I.V., Sidorenko V.A. i dr. Molekuly adgezii i provospalitel'nye tsitokiny v spinnomozgovoi zhidkosti bol'nykh rasseyannym sklerozom. Byul sib meditsiny 2009; 8: 2: 23-26.
  3. Malkova N.A., Ierusalimskii A.P. Rasseyannyi skleroz. Novosibirsk: NGMU 2006; 198.
  4. Mironova I.I., Romanova L.A., Dolgov V.V. Obshcheklinicheskie issledovaniya: mocha, kal, likvor, eyakulyat. M-Tver': Triada 2005; 206.
  5. Totolyan N.A., Trofimova T.N., Pakhomov A.V. Magnitno-rezonansnaya tomografiya: diagnostika i differentsial'naya diagnostika vospalitel'nykh demieliniziruyushchikh zabolevanii: uchebnoe posobie. St-Peterburg: NIIEM im. Pastera 2009; 56.
  6. Shmidt T.E., Yakhno N.N. Rasseyannyi skleroz: rukovodstvo dlya vrachei. 2-e izd. M: MEDpress-inform 2010; 272.
  7. Axelsson M., Malmeström C., Nilsson S. et al. Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis. J Neurology 2011; 258: 5: 882-888.
  8. Droogan A.G., McMillan S.A., Douglas J.P. et al. Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vasculae cell adhesion molecule 1. J Neuroimmunol 1996; 64: 185-191.
  9. Elovaara I., Ukkonen M., Leppakynnas M. et al. Adhesion Molecules in Multiple Sclerosis. Relation to Subtypes of Disease and Methylprednisolone. Therapy Arch Neurology 2000; 57: 546-551.
  10. Freedman M.S., Thompson E.J., Deisenhammer F. et al. Arch Neurol 2005; 62: 268-375.
  11. Katz D., Taubenberger J.K., Cannella B. et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993; 34: 661-669.
  12. Kuenz B., Lutterotti A., Khalil M. et al. Links plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis. J Neuroimmunol 2005; 167:143-149.
  13. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 12: 1444-1452.
  14. Minagar A., Alexander J.S. Blood-brain barrier disruption in multiple sclerosis. Multiple Sclerosis 2003; 9: 540-549.
  15. Polman C.H., Reingold S.C., Edan C. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald'. Ann Neurol 2005; 6: 840-864.
  16. Salzer J., Svenningsson A., Sundstrom P. Neurofilament light as a prognostic marker in multiple sclerosis. Mult Scler 2010; 16: 3: 287.
  17. Simon J.H. Contrast-enhanced MR imaging in the evaluation of treatment response and prediction of outcome in multiple sclerosis. J Magn Reson Imaging 1997; 7: 29-37.
  18. Truyen L., van Waesberghe T.H.T.M., Barkof F. et al. Accumulation of hypointense lesions ("black holes") on T1 spin echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996; 47: 1469-1476.
  19. Waesberghe J.H., Castelijns J.A., Scheltens P. et al. Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. Magn Reson Imaging 1997; 15: 155-162.
  20. Walderveen M.A.A., Kamphorst W., Scheltens P. et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998; 50: 1282-1288.
  21. Washington R., Burton J., Todd R.F. et al. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann Neurol 1994; 5: 89-97.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.